{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:06:35Z","timestamp":1761825995351,"version":"build-2065373602"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Ulm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To apply quantitative imaging analysis for noninvasive classification of the most frequent subtypes of Non-Hodgkin Lymphoma (NHL) as a basis for a clinical imaging genomic model to support therapeutic monitoring and clinical decision making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      In this single-center study, 201 treatment-na\u00efve patients with biopsy-proven NHL (50 diffuse large B-cell lymphoma [DLBCL], 51 mantle cell lymphoma [MCL], 49 follicular lymphoma [FL], and 51 chronic lymphocytic leukemia [CLL]) and 39 treatment-na\u00efve non-small cell lung cancer patients with positron emission tomography (PET)\/computed tomography (CT)-confirmed healthy axillary lymph nodes (LNs) were retrospectively analyzed. Three-dimensional (3D) segmentation and radiomic analysis of pathologically enlarged nodes (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091,628) were performed on contrast-enhanced CT scans, including healthy LNs as references. Feature selection was performed using a random forest (RF) classifier. Multiclass Classifier was performed using a Light Gradient Boosting Machine (LGBM) classifier for lymphoma subtype classification.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Performance to classify lymphoma from non-lymphoma and lymphoma subtypes was as follows: lymphoma vs. non-lymphoma: area under the curve (AUC)\u2009=\u20090.999; MCL vs. other NHL: AUC\u2009=\u20090.997; DLBCL vs. other NHL: AUC\u2009=\u20090.971; CLL vs. other NHL: AUC\u2009=\u20090.956; FL vs. other NHL: AUC\u2009=\u20090.892.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Radiomics combined with multiclass machine learning enables highly accurate, non-invasive differentiation of the major NHL subtypes on routine contrast-enhanced CT. By reliably separating indolent from aggressive phenotypes, this approach lays the groundwork for imaging-genomic models that could streamline biopsy guidance, enhance therapeutic monitoring, and advance precision oncology in lymphoma care.Conducted as a single-centre, retrospective proof-of-concept with internal patient-level cross-validation, these results are promising and form the basis for a prospective multicentre study to confirm generalisability and clinical utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical relevance statement<\/jats:title>\n                    <jats:p>Accurate lymphoma classification is essential for predicting clinical behavior and guiding treatment. Imaging aids in disease staging, with quantitative analysis showing promise in predicting pathology and outcome. We explored machine learning on imaging features for lymphoma classification, thus enhancing clinical decisions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12880-025-02006-3","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:02:03Z","timestamp":1761825723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-Hodgkin\u2019s lymphoma classification using 3D radiomics machine learning models for precision imaging in oncology"],"prefix":"10.1186","volume":"25","author":[{"given":"Christoph G.","family":"Lisson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"G\u00f6tz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabitha","family":"Manoj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Gallee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan A.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Tausch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Stilgenbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambros J.","family":"Beer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meinrad","family":"Beer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"Sollmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina S.","family":"Lisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"2006_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"2006_CR2","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, Brousset P, Cerroni L, de Leval L, Dirnhofer S. The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood J Am Soc Hematol. 2022;140:1229\u201353. https:\/\/doi.org\/10.1182\/blood.2022015851.","journal-title":"Blood J Am Soc Hematol"},{"key":"2006_CR3","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IB, de O, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720\u201348. https:\/\/doi.org\/10.1038\/s41375-022-01620-2.","journal-title":"Leukemia"},{"key":"2006_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13045-021-01054-w","volume":"14","author":"K Patel","year":"2021","unstructured":"Patel K, Pagel JM. Current and future treatment strategies in chronic lymphocytic leukemia. J Hematol Oncol. 2021;14:69. https:\/\/doi.org\/10.1186\/s13045-021-01054-w.","journal-title":"J Hematol Oncol"},{"key":"2006_CR5","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/14656566.2020.1737010","volume":"21","author":"DL Kienle","year":"2020","unstructured":"Kienle DL, Stilgenbauer S. Approved and emerging PI3K inhibitors for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma. Expert Opin Pharmacother. 2020;21:917\u201329. https:\/\/doi.org\/10.1080\/14656566.2020.1737010.","journal-title":"Expert Opin Pharmacother"},{"key":"2006_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.humpath.2019.08.019","volume":"95","author":"SH Swerdlow","year":"2020","unstructured":"Swerdlow SH, Cook JR. As the world turns, evolving lymphoma classifications\u2013past, present and future. Hum Pathol. 2020;95:55\u201377. https:\/\/doi.org\/10.1016\/j.humpath.2019.08.019.","journal-title":"Hum Pathol"},{"key":"2006_CR7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000475530","volume":"85","author":"CM Sch\u00fcrch","year":"2018","unstructured":"Sch\u00fcrch CM, Federmann B, Quintanilla-Martinez L, Fend F. Tumor heterogeneity in lymphomas: a different breed. Pathobiology. 2018;85:130\u201345. https:\/\/doi.org\/10.1159\/000475530.","journal-title":"Pathobiology"},{"key":"2006_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.beha.2018.07.008","volume":"31","author":"J Godfrey","year":"2018","unstructured":"Godfrey J, Leukam MJ, Smith SM. An update in treating transformed lymphoma. Best Pract Res Clin Haematol. 2018;31:251\u201361. https:\/\/doi.org\/10.1016\/j.beha.2018.07.008.","journal-title":"Best Pract Res Clin Haematol"},{"key":"2006_CR9","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.hoc.2016.07.012","volume":"30","author":"MA Anderson","year":"2016","unstructured":"Anderson MA, Blombery P, Seymour JF. Transformed lymphoma. Hematol Clin. 2016;30:1317\u201332. https:\/\/doi.org\/10.1016\/j.hoc.2016.07.012.","journal-title":"Hematol Clin"},{"key":"2006_CR10","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.3390\/cancers13102419","volume":"13","author":"G Steinbuss","year":"2021","unstructured":"Steinbuss G, Kriegsmann M, Zgorzelski C, Brobeil A, Goeppert B, Dietrich S, Mechtersheimer G, Kriegsmann K. Deep learning for the classification of Non-Hodgkin lymphoma on histopathological images. Cancers. 2021;13:2419. https:\/\/doi.org\/10.3390\/cancers13102419.","journal-title":"Cancers"},{"key":"2006_CR11","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1016\/S2352-3026(20)30365-3","volume":"8","author":"SF Barrington","year":"2021","unstructured":"Barrington SF, Trotman J. The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma. Lancet Haematol. 2021;8:e80\u201393. https:\/\/doi.org\/10.1016\/S2352-3026(20)30365-3.","journal-title":"Lancet Haematol"},{"key":"2006_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278:563. https:\/\/doi.org\/10.1148\/radiol.2015151169.","journal-title":"Radiology"},{"key":"2006_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, Van Stiphout RG, Granton P, Zegers CM, Gillies R, Boellard R, Dekker A. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48:441\u20136. https:\/\/doi.org\/10.1016\/j.ejca.2011.11.036.","journal-title":"Eur J Cancer"},{"key":"2006_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, Peerlings J, De Jong EEC, Van Timmeren J, Sanduleanu S, Larue RTHM, Even AJG, Jochems A. Radiomics: the Bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14:749\u201362. https:\/\/doi.org\/10.1038\/nrclinonc.2017.141.","journal-title":"Nat Rev Clin Oncol"},{"key":"2006_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJ Aerts","year":"2014","unstructured":"Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:1\u20139. https:\/\/doi.org\/10.1038\/ncomms5006.","journal-title":"Nat Commun"},{"key":"2006_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13244-012-0196-6","volume":"3","author":"F Davnall","year":"2012","unstructured":"Davnall F, Yip CS, Ljungqvist G, Selmi M, Ng F, Sanghera B, Ganeshan B, Miles KA, Cook GJR, Goh V. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging. 2012;3:573\u201389. https:\/\/doi.org\/10.1007\/s13244-012-0196-6.","journal-title":"Insights Imaging"},{"key":"2006_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature12625","volume":"501","author":"RA Burrell","year":"2013","unstructured":"Burrell RA, McGranahan N, Bartek J, Swanton C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013;501:338\u201345. https:\/\/doi.org\/10.1038\/nature12625.","journal-title":"Nature"},{"key":"2006_CR18","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1007\/s00330-016-4470-8","volume":"27","author":"B Ganeshan","year":"2017","unstructured":"Ganeshan B, Miles KA, Babikir S, Shortman R, Afaq A, Ardeshna K, Groves AM, Kayani I. CT-based texture analysis potentially provides prognostic information complementary to interim FDG-PET for patients with hodgkin\u2019s and aggressive non-Hodgkin\u2019s lymphomas. Eur Radiol. 2017;27:1012\u201320. https:\/\/doi.org\/10.1007\/s00330-016-4470-8.","journal-title":"Eur Radiol"},{"key":"2006_CR19","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1007\/s00330-019-06495-z","volume":"30","author":"B Baessler","year":"2020","unstructured":"Baessler B, Nestler T, Pinto dos Santos D, Paffenholz P, Zeuch V, Pfister D, Maintz D, Heidenreich A. Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to Post\u2013Chemotherapy retroperitoneal lymph node dissection. Eur Radiol. 2020;30:2334\u201345. https:\/\/doi.org\/10.1007\/s00330-019-06495-z.","journal-title":"Eur Radiol"},{"key":"2006_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41747-019-0143-0","volume":"4","author":"R Gatta","year":"2020","unstructured":"Gatta R, Depeursinge A, Ratib O, Michielin O, Leimgruber A. Integrating radiomics into holomics for personalised oncology: from algorithms to bedside. Eur Radiol Exp. 2020;4:1\u20139. https:\/\/doi.org\/10.1186\/s41747-019-0143-0.","journal-title":"Eur Radiol Exp"},{"key":"2006_CR21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s00330-017-5014-6","volume":"28","author":"CS Lisson","year":"2018","unstructured":"Lisson CS, Lisson CG, Flosdorf K, Mayer-Steinacker R, Schultheiss M, von Baer A, Barth TFE, Beer AJ, Baumhauer M, Meier R, et al. Diagnostic value of MRI-based 3D texture analysis for tissue characterisation and discrimination of low-grade chondrosarcoma from enchondroma: a pilot study. Eur Radiol. 2018;28:468\u201377. https:\/\/doi.org\/10.1007\/s00330-017-5014-6.","journal-title":"Eur Radiol"},{"key":"2006_CR22","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00259-021-05626-3","volume":"49","author":"FM de Jesus","year":"2022","unstructured":"de Jesus FM, Yin Y, Mantzorou-Kyriaki E, Kahle X, de Haas R, Yakar D, Glaudemans AW, Noordzij W, Kwee T, Nijland M. Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [18F] FDG PET\/CT features. Eur J Nucl Med Mol Imaging. 2022;49:1535\u201343. https:\/\/doi.org\/10.1007\/s00259-021-05626-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2006_CR23","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1007\/s00330-019-06291-9","volume":"29","author":"CP Reinert","year":"2019","unstructured":"Reinert CP, Federmann B, Hofmann J, B\u00f6sm\u00fcller H, Wirths S, Fritz J, Horger M. Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome. Eur Radiol. 2019;29:6911\u201321. https:\/\/doi.org\/10.1007\/s00330-019-06291-9.","journal-title":"Eur Radiol"},{"key":"2006_CR24","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.acra.2016.01.012","volume":"23","author":"X Wu","year":"2016","unstructured":"Wu X, Siki\u00f6 M, Pertovaara H, J\u00e4rvenp\u00e4\u00e4 R, Eskola H, Dastidar P, Kellokumpu-Lehtinen P-L. Differentiation of diffuse large B-cell lymphoma from follicular lymphoma using texture analysis on conventional MR images at 3.0 Tesla. Acad Radiol. 2016;23:696\u2013703. https:\/\/doi.org\/10.1016\/j.acra.2016.01.012.","journal-title":"Acad Radiol"},{"key":"2006_CR25","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1007\/s00330-018-5368-4","volume":"28","author":"HB Suh","year":"2018","unstructured":"Suh HB, Choi YS, Bae S, Ahn SS, Chang JH, Kang S-G, Kim EH, Kim SH, Lee S-K. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using radiomics approach. Eur Radiol. 2018;28:3832\u20139. https:\/\/doi.org\/10.1007\/s00330-018-5368-4.","journal-title":"Eur Radiol"},{"key":"2006_CR26","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1016\/j.acra.2018.07.021","volume":"26","author":"Z Huang","year":"2019","unstructured":"Huang Z, Li M, He D, Wei Y, Yu H, Wang Y, Yuan F, Song B. Two-dimensional texture analysis based on CT images to differentiate pancreatic lymphoma and pancreatic adenocarcinoma: a preliminary study. Acad Radiol. 2019;26:e189\u201395. https:\/\/doi.org\/10.1016\/j.acra.2018.07.021.","journal-title":"Acad Radiol"},{"key":"2006_CR27","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/cam4.2711","volume":"9","author":"X Ou","year":"2020","unstructured":"Ou X, Zhang J, Wang J, Pang F, Wang Y, Wei X, Ma X. Radiomics based on 18F-FDG PET\/CT could differentiate breast carcinoma from breast lymphoma using machine\u2010learning approach: A preliminary study. Cancer Med. 2020;9:496\u2013506. https:\/\/doi.org\/10.1002\/cam4.2711.","journal-title":"Cancer Med"},{"key":"2006_CR28","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3389\/fonc.2019.00844","volume":"9","author":"H Xu","year":"2019","unstructured":"Xu H, Guo W, Cui X, Zhuo H, Xiao Y, Ou X, Zhao Y, Zhang T, Ma X. Three-dimensional texture analysis based on PET\/CT images to distinguish hepatocellular carcinoma and hepatic lymphoma. Front Oncol. 2019;9:844. https:\/\/doi.org\/10.3389\/fonc.2019.00844.","journal-title":"Front Oncol"},{"key":"2006_CR29","doi-asserted-by":"publisher","first-page":"e537","DOI":"10.1016\/j.ejrad.2013.06.024","volume":"82","author":"A Ba-Ssalamah","year":"2013","unstructured":"Ba-Ssalamah A, Muin D, Schernthaner R, Kulinna-Cosentini C, Bastati N, Stift J, Gore R, Mayerhoefer ME. Texture-based classification of different gastric tumors at contrast-enhanced CT. Eur J Radiol. 2013;82:e537\u201343. https:\/\/doi.org\/10.1016\/j.ejrad.2013.06.024.","journal-title":"Eur J Radiol"},{"key":"2006_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejrad.2017.04.007","volume":"91","author":"Z Ma","year":"2017","unstructured":"Ma Z, Fang M, Huang Y, He L, Chen X, Liang C, Huang X, Cheng Z, Dong D, Liang C. CT-based radiomics signature for differentiating Borrmann type IV gastric cancer from primary gastric lymphoma. Eur J Radiol. 2017;91:142\u20137. https:\/\/doi.org\/10.1016\/j.ejrad.2017.04.007.","journal-title":"Eur J Radiol"},{"key":"2006_CR31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579\u201386. https:\/\/doi.org\/10.1200\/JCO.2006.09.2403.","journal-title":"J Clin Oncol"},{"key":"2006_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg A, Valli\u00e8res M, Abdalah MA, Aerts HJ, Andrearczyk V, Apte A, Ashrafinia S, Bakas S, Beukinga RJ, Boellaard R. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295:328\u201338. https:\/\/doi.org\/10.1148\/radiol.2020191145.","journal-title":"Radiology"},{"key":"2006_CR33","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1007\/s00330-020-06927-1","volume":"30","author":"H Wang","year":"2020","unstructured":"Wang H, Zhou Y, Li L, Hou W, Ma X, Tian R. Current status and quality of radiomics studies in lymphoma: a systematic review. Eur Radiol. 2020;30:6228\u201340. https:\/\/doi.org\/10.1007\/s00330-020-06927-1.","journal-title":"Eur Radiol"},{"key":"2006_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40336-023-00604-1","volume":"12","author":"L Filippi","year":"2024","unstructured":"Filippi L, Ferrari C, Nuvoli S, Bianconi F, Donner D, Marongiu A, Mammucci P, Vultaggio V, Chierichetti F, Rubini G, et al. Pet-radiomics in lymphoma and multiple myeloma: update of current literature. Clin Transl Imaging. 2024;12:119\u201335. https:\/\/doi.org\/10.1007\/s40336-023-00604-1.","journal-title":"Clin Transl Imaging"},{"key":"2006_CR35","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/jmri.27900","volume":"55","author":"Q Xu","year":"2022","unstructured":"Xu Q, Zhu Q, Liu H, Chang L, Duan S, Dou W, Li S, Ye J. Differentiating benign from malignant renal tumors using T2-and Diffusion\u2010Weighted images: A comparison of deep learning and radiomics models versus assessment from radiologists. J Magn Reson Imaging. 2022;55:1251\u20139. https:\/\/doi.org\/10.1002\/jmri.27900.","journal-title":"J Magn Reson Imaging"},{"key":"2006_CR36","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1177\/0284185115598808","volume":"57","author":"MB Andersen","year":"2016","unstructured":"Andersen MB, Harders SW, Ganeshan B, Thygesen J, Madsen HHT, Rasmussen F. CT texture analysis can help differentiate between malignant and benign lymph nodes in the mediastinum in patients suspected for lung cancer. Acta Radiol. 2016;57:669\u201376. https:\/\/doi.org\/10.1177\/0284185115598808.","journal-title":"Acta Radiol"},{"key":"2006_CR37","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s00330-014-3420-6","volume":"25","author":"H Bayanati","year":"2015","unstructured":"Bayanati H, Thornhill E, Souza R, Sethi-Virmani CA, Gupta V, Maziak A, Amjadi D, Dennie K. Quantitative CT texture and shape analysis: can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer? Eur Radiol. 2015;25:480\u20137. https:\/\/doi.org\/10.1007\/s00330-014-3420-6.","journal-title":"Eur Radiol"},{"key":"2006_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s12885-018-4432-4","volume":"18","author":"JMM Rogasch","year":"2018","unstructured":"Rogasch JMM, Hundsdoerfer P, Hofheinz F, Wedel F, Schatka I, Amthauer H, Furth C. Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric hodgkin\u2019s lymphoma. BMC Cancer. 2018;18:521. https:\/\/doi.org\/10.1186\/s12885-018-4432-4.","journal-title":"BMC Cancer"},{"key":"2006_CR39","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41598-018-37197-z","volume":"9","author":"SA Milgrom","year":"2019","unstructured":"Milgrom SA, Elhalawani H, Lee J, Wang Q, Mohamed ASR, Dabaja BS, Pinnix CC, Gunther JR, Court L, Rao A, et al. A PET radiomics model to predict refractory mediastinal hodgkin lymphoma. Sci Rep. 2019;9:1322. https:\/\/doi.org\/10.1038\/s41598-018-37197-z.","journal-title":"Sci Rep"},{"key":"2006_CR40","doi-asserted-by":"publisher","first-page":"101188","DOI":"10.1016\/j.tranon.2021.101188","volume":"14","author":"R Santiago","year":"2021","unstructured":"Santiago R, Ortiz Jimenez J, Forghani R, Muthukrishnan N, Del Corpo O, Karthigesu S, Haider MY, Reinhold C, Assouline S. CT-based radiomics model with machine learning for predicting primary treatment failure in diffuse large B-cell lymphoma. Transl Oncol. 2021;14:101188. https:\/\/doi.org\/10.1016\/j.tranon.2021.101188.","journal-title":"Transl Oncol"},{"key":"2006_CR41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/cancers14020393","volume":"14","author":"CS Lisson","year":"2022","unstructured":"Lisson CS, Lisson CG, Achilles S, Mezger MF, Wolf D, Schmidt SA, Thaiss WM, Bloehdorn J, Beer AJ, Stilgenbauer S. Longitudinal CT imaging to explore the predictive power of 3D radiomic tumour heterogeneity in precise imaging of mantle cell lymphoma (MCL). Cancers. 2022;14:393. https:\/\/doi.org\/10.3390\/cancers14020393.","journal-title":"Cancers"},{"key":"2006_CR42","doi-asserted-by":"publisher","first-page":"105153","DOI":"10.1016\/j.cmpb.2019.105153","volume":"185","author":"M Lippi","year":"2020","unstructured":"Lippi M, Gianotti S, Fama A, Casali M, Barbolini E, Ferrari A, Fioroni F, Iori M, Luminari S, Menga M, et al. Texture analysis and multiple-instance learning for the classification of malignant lymphomas. Comput Methods Programs Biomed. 2020;185:105153. https:\/\/doi.org\/10.1016\/j.cmpb.2019.105153.","journal-title":"Comput Methods Programs Biomed"},{"key":"2006_CR43","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/cancers14030713","volume":"14","author":"JS Enke","year":"2022","unstructured":"Enke JS, Moltz JH, D\u2019Anastasi M, Kunz WG, Schmidt C, Maurus S, M\u00fchlberg A, Katzmann A, S\u00fchling M, Hahn H, et al. Radiomics features of the spleen as surrogates for CT-Based lymphoma diagnosis and subtype differentiation. Cancers. 2022;14:713. https:\/\/doi.org\/10.3390\/cancers14030713.","journal-title":"Cancers"},{"key":"2006_CR44","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.3390\/cancers17091480","volume":"17","author":"N Pugliese","year":"2025","unstructured":"Pugliese N, Picardi M, Giordano C, Vincenzi A, Cappiello R, Mascolo M, Pane F. Elastography enhances the diagnostic performance of conventional ultrasonography in differentiating benign from malignant superficial lymphadenopathies. Cancers. 2025;17:1480. https:\/\/doi.org\/10.3390\/cancers17091480.","journal-title":"Cancers"},{"key":"2006_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/pro6.70005","volume":"9","author":"J Xu","year":"2025","unstructured":"Xu J, Zhang L, Liu Q, Zhu J. Preoperative multiparameter MRI-based prediction of Ki\u201067 expression in primary central nervous system lymphoma. Precis Radiat Oncol. 2025;9:23\u201334. https:\/\/doi.org\/10.1002\/pro6.70005.","journal-title":"Precis Radiat Oncol"},{"key":"2006_CR46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12874-019-0681-4","volume":"19","author":"JAM Sidey-Gibbons","year":"2019","unstructured":"Sidey-Gibbons JAM, Sidey-Gibbons CJ. Machine learning in medicine: a practical introduction. BMC Med Res Methodol. 2019;19:64. https:\/\/doi.org\/10.1186\/s12874-019-0681-4.","journal-title":"BMC Med Res Methodol"},{"key":"2006_CR47","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJMra1814259","volume":"380","author":"A Rajkomar","year":"2019","unstructured":"Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019;380:1347\u201358. https:\/\/doi.org\/10.1056\/NEJMra1814259.","journal-title":"N Engl J Med"},{"key":"2006_CR48","doi-asserted-by":"publisher","first-page":"13087","DOI":"10.1038\/srep13087","volume":"5","author":"C Parmar","year":"2015","unstructured":"Parmar C, Grossmann P, Bussink J, Lambin P, Aerts HJWL. Machine learning methods for quantitative radiomic biomarkers. Sci Rep. 2015;5:13087. https:\/\/doi.org\/10.1038\/srep13087.","journal-title":"Sci Rep"},{"key":"2006_CR49","doi-asserted-by":"publisher","first-page":"101840","DOI":"10.1109\/ACCESS.2020.2997330","volume":"8","author":"F Alzamzami","year":"2020","unstructured":"Alzamzami F, Hoda M, El Saddik A. Light gradient boosting machine for general sentiment classification on short texts: a comparative evaluation. IEEE Access. 2020;8:101840\u201358. https:\/\/doi.org\/10.1109\/ACCESS.2020.2997330.","journal-title":"IEEE Access"},{"key":"2006_CR50","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, Lawrence MS, Roemer MGM, Li AJ, Ziepert M, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24:679\u201390. https:\/\/doi.org\/10.1038\/s41591-018-0016-8.","journal-title":"Nat Med"},{"key":"2006_CR51","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, Roulland S, Kasbekar M, Young RM, Shaffer AL, et al. Genetics and pathogenesis of diffuse large B-Cell lymphoma. N Engl J Med. 2018;378:1396\u2013407. https:\/\/doi.org\/10.1056\/NEJMoa1801445.","journal-title":"N Engl J Med"},{"key":"2006_CR52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.21037\/aol-21-5","volume":"5","author":"M Perrett","year":"2021","unstructured":"Perrett M, Okosun J. Genetic heterogeneity in follicular lymphoma. Ann Lymphoma. 2021;5:18\u201318. https:\/\/doi.org\/10.21037\/aol-21-5.","journal-title":"Ann Lymphoma"},{"key":"2006_CR53","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1182\/blood-2012-09-458265","volume":"121","author":"D Rossi","year":"2013","unstructured":"Rossi D, Rasi S, Spina V, Bruscaggin A, Monti S, Ciardullo C, Deambrogi C, Khiabanian H, Serra R, Bertoni F, et al. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood. 2013;121:1403\u201312. https:\/\/doi.org\/10.1182\/blood-2012-09-458265.","journal-title":"Blood"},{"key":"2006_CR54","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/cancers17040696","volume":"17","author":"A Ip","year":"2025","unstructured":"Ip A, Kabat M, Fogel L, Alkhatatneh H, Voss J, Gupta A, Della Pia A, Leslie LA, Feldman T, Albitar M, et al. Updates on the biological heterogeneity of mantle cell lymphoma. Cancers. 2025;17:696. https:\/\/doi.org\/10.3390\/cancers17040696.","journal-title":"Cancers"},{"key":"2006_CR55","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12916-025-03893-7","volume":"23","author":"C Jiang","year":"2025","unstructured":"Jiang C, Qian C, Jiang Q, Zhou H, Jiang Z, Teng Y, Xu B, Li X, Ding C, Tian R. Virtual biopsy for non-invasive identification of follicular lymphoma histologic transformation using radiomics-based imaging biomarker from PET\/CT. BMC Med. 2025;23:49. https:\/\/doi.org\/10.1186\/s12916-025-03893-7.","journal-title":"BMC Med"},{"key":"2006_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13244-019-0705-y","volume":"10","author":"F Alessandrino","year":"2019","unstructured":"Alessandrino F, DiPiro PJ, Jagannathan JP, Babina G, Krajewski KM, Ramaiya NH, Giardino AA. Multimodality imaging of indolent B cell lymphoma from diagnosis to transformation: what every radiologist should know. Insights Imaging. 2019;10:1\u201312.","journal-title":"Insights Imaging"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02006-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-02006-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02006-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:02:03Z","timestamp":1761825723000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-02006-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2006"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-02006-3","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Medical Faculty of the University of Ulm (protocol code 378\/24, approved on 21 November 2024). As it was a retrospective study, the requirement for written informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. As this was a retrospective study using anonymized data, no individual consent for publication was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"435"}}